Title: 
Headings: 

Content: Mona Barmash, Children’s Heart Information Network • Holy Cross Hospital
CongHrt_Cover&Tabs9x11  10/11/11  12:56 PM  Page 2
User Agreement
♥Section 1 – Program Overview
Vision Pulse Oximetry Screening for Congenital Heart Disease: Who, What, When, Where, and Why? Opening Letter Screening Recommendations Letter to Providers Supplies for Screening Screening Form ♥Section 2 – Screener Training
In-Service Education Program Components Congenital Heart Disease Screening Program: Education for Providers Performing Pulse Oximetry with the Infant Patient: Education for Providers Pulse Ox Probe Placement Education Knowledge Assessment and Answer Key Competency Check List Training Log CHDSP PowerPoint Presentation Information ♥Section 3 – Education for Parents and Guardians
Checklist for Informing Mothers Frequently Asked Questions (FAQs) for Patients and Families Frequently Asked Questions (FAQs) for Patients and Families (Spanish) Congenital Heart Disease Screening Program: For Patients and Families Congenital Heart Disease Screening Program: For Patients and Families (Spanish) CHD Resources CHD Resources (Spanish) ♥Section 4 – Advocacy
♥Section 5 – References and Resource Lists
Table of Contents
Children’s National Medical Center’s Congenital Heart Disease Screening Program
Congenital Heart Disease Screening Program♥
4
A. Terms and Conditions
Please read this agreement in its entirety prior to use. The Congenital Heart Disease Screening Program Toolkit (“Toolkit”) is designed to serve as a guide to healthcare providers seeking to use pulse oximetry as a screening tool for critical congenital heart disease in the newborn nursery. By utilizing this Toolkit, you agree to the terms and conditions that follow. B. Disclaimer
Recommendations provided by Children’s National Medical Center are derived from a review of evidence- based literature on pulse oximetry screening for critical congenital heart disease and outcomes of the clinical research study titled “Feasibility of Implementation of Pulse Oximetry as a Screening Tool for Critical Congenital Heart Disease in the Newborn Nursery.”